Article info
PDFElectronic pages
Correspondence
In the idiopathic inflammatory myopathies, reactive oxygen species are at the crossroad between immune and non-immune cell-mediated mechanisms
- Correspondence to Dr Alain Meyer, Exploration fonctionnelle musculaire, Hôpitaux Universitaires de Strasbourg de Strasbourg, Fédération de Médecine Translationnelle, Strasbourg 67000, France; alain.meyer1{at}chru-strasbourg.fr
Citation
In the idiopathic inflammatory myopathies, reactive oxygen species are at the crossroad between immune and non-immune cell-mediated mechanisms
Publication history
- Accepted July 24, 2015
- First published August 14, 2015.
Online issue publication
June 30, 2016
Article Versions
- Previous version (30 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions